The S&P 500 eyes a breakout above 7000 while the US dollar shows mixed momentum against the Mexican peso. Gold remains a buy-on-the-dip play near 4800, and Bitcoin finds stability above the critical $60,000 support level.

Belgium’s Court of Audit warns that fiscal reforms may fail to restore public finances as structural goals clash with deficit targets. Prime Minister Bart De Wever must now find up to €6 billion in extra savings to bridge the gap.

WTI crude oil surged to $67 as President Trump’s warning of a potential strike on Iran fueled Middle East supply fears. A bullish golden cross and double-bottom pattern suggest prices may soon challenge the $70 psychological resistance level.

The Nasdaq 100 is likely completing a primary third wave, signaling a sharp correction ahead. Key support sits at 23,854, with NVIDIA (NVDA) earnings and geopolitical risks poised to challenge the current market topping process.

SMID-cap biotechs offer prime value as the healthcare sector navigates a mid-February lull. QuidelOrtho and Axsome Therapeutics highlight key trades as the Russell 2000 signals a potential upward cycle.